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Abstract: Rheumatoid arthritis is a systemic autoimmune disease of uncertain aetiology, which is characterized primarily 
by synovial inflammation with secondary skeletal destructions. 
Rheumatoid Arthritis is diagnosed by the presence of four of the seven diagnostic criteria, defined by The American 
College of Rheumatology. 
Approximately half a million adults in the United Kingdom suffer from rheumatoid arthritis with an age prevalence 
between the second and fourth decades of life; annually approximately 20,000 new cases are diagnosed. 
The management of Rheumatoid Arthritis is complex; in the initial phase of the disease it primarily depends on 
pharmacological management. With disease progression, surgical input to correct deformity comes to play an increasingly 
important role. The treatment of this condition is also intimately coupled with input from both the occupational therapists 
and physiotherapy. 
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  Rheumatoid arthritis is a systemic, autoimmune disease 
of uncertain aetiology, which is characterized primarily by 
synovial inflammation with secondary skeletal destructions 
[1]. 
  It is a chronic disease that challenges individuals 
psychosocially as well as physically, causing a great deal of 
stress to those living with this pathology [2, 3]. The stress 
resulting from the inability to perform simple day to day 
tasks independently, the associated discomfort and the insult 
to patient’s aesthetic sensibilities result in high levels of 
depression in this group; at approximately 20% it is twice 
that of the general population [4]. It is well recognised that 
occupation, including paid employment has a large influence 
on personal well being and society as a whole [5-8]. 
  Coming from the Greek rheuma- (“
μ-” meaning 
flux) and -toid (“-
	” meaning form) [9] it describes a 
condition were synovial and articular tissues are focal target 
structures; the immunologic disorder frequently affects 
disparate visceral organs such as the heart, pericardium, and 
lungs [1]. 
  This article aims to discuss and summarise the current 
perspective of Rheumatoid Arthritis in terms of 
epidemiology and pathophysiology as well as considering 
any new ideas in management of this condition. 
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RHEUMATOID ARTHRITIS: DIAGNOSIS, CLASSI-
FICATION, EPIDEMIOLOGY AND GENETIC BACK-
GROUND 
Diagnosis & Classification 
  Rheumatoid arthritis is a term that describes a condition 
were synovial and articular tissues are focal target structures. 
This immunologic disorder frequently affects various 
visceral organs such as the heart, pericardium, and lungs [1]. 
  Numerous combinations of clinical findings exist and 
have been named after the person to first describe them. 
These eponymous forms of Rheumatoid arthritis include 
Adult Stills Syndrome, Feltey’s, Sjogren’s as well as 
Caplan’s Syndrome [10] (Table 1). 
  Juvenile Rheumatoid Arthritis (JRA) usually occurs 
before the age of sixteen; symptoms may start as early as six 
months old [11, 12]. 
  Eponymous syndromes of JRA include: Polyarthritic-
systemic Juvenile Chronic Arthritis (JCA), Polyarthritic-non-
systemic seronegative JCA, Polyarthritic-non-systemic 
seropositive JCA, Oligoarthritis I and finally Oligoarthritis II 
[10] (Table 2). 
  Clinically Rheumatoid Arthritis is diagnosed by the 
presence of four of the seven diagnostic criteria, defined by 
The American College of Rheumatology [13] (Table 3). 
  Morning stiffness lasting over one hour, symmetrical 
arthritis, arthritis affecting three or more joint areas and 
arthritis of the hand joints must be present for at least six 
weeks before rheumatoid arthritis can be diagnosed [13]. Rheumatoid Arthritis and Hand Surgery  The Open Orthopaedics Journal, 2012, Volume 6    89 
Table  1. The Different Types of Juvenile Syndromic 
Rheumatoid Arthritis and their Clinical Signs 
 
Eponymous Juvenile 
Rheumatoid Arthritis  Associated Clinical Signs  
Polyarthritic-systemic Juvenile  
Chronic Arthritis (JCA) 
Early childhood with fever,  
sometimes severe organ manifestations 
Polyarthritic-non-systemic  
seronegative JCA 
Largest group 
Polyarthritic-non-systemic  
seropositive JCA 
Mainly girls in late childhood, Anti-nuclear 
 antibodies positive in 77% 
Oligoarthritis I 
 (“early type”) 
Mainly girls, Chronic  
Iridocyclitis, ANA positive 
Oligoarthritis II  
(“late type”) 
Mainly boys, fewer joints (esp. knee),  
Sacroiliitis, HLA-B27 positive,  
may develop Ankylosing Spondilitis 
 
Table  2. The Different Types of Adult Syndromic 
Rheumatoid Arthritis and their Clinical Signs 
 
Eponymous Rheumatoid  
Arthritis  
Associated Clinical Signs  
Adult Stills Syndrome 
Chronic Polyarthritis, Hepatomegaly,  
Splenomegaly, Lymphadenopathy,  
Leucocytosis, Iridocyclitis, Polyserositis 
Feltey’s Syndrome 
Seropositive RA, Splenomegaly,  
Lymphadenopathy, Leucopaenia,  
Granulocytopaenia, Thrombocytopaenia 
Sjogren’s Syndrome  Xerophthalmia, Xerostomia,  
Sicca Syndrome (1ry&2ry) 
Caplan’s Syndrome  Pneumoconiosis, RA 
 
Table 3.  The American College of Rheumatology Diagnostic 
Criteria for Rheumatoid Arthritis 
 
  Diagnostic Criteria for Rheumatoid Arthritis 
1  Morning stiffness 
2  Symmetrical Arthritis 
3  Arthritis of Hand Joints 
4  Arthritis of tree or more joints 
5  Rheumatoid nodules 
6  Serum Rheumatoid Factor positive 
7  Typical radiological changes in the hands and feet 
 
  Haematological investigation includes base line 
inflammatory markers, in addition to the rheumatoid factor. 
This however is only helpful in seropositive patients. 
Anticyclic citrullinated peptide antibody is highly specific 
for the disease and is particularly useful both in the diagnosis 
and prognosis of patients who are seronegative, for the 
rheumatoid factor [14]. 
  Radiologically, Steinbroker published his findings of the 
radiographic stages of Rheumatoid Arthritis in a mixed, 
clinical-radiographic classification in 1949 [15]. This is 
based on the combination of radiological staging with 
clinical findings; it includes stage I where osteoporosis 
without erosions is seen, stage II where osteoporosis, slight 
narrowing of the joint space or subchondral bone destruction 
is evident; stage III with osteoporosis, destruction of the 
articular cartilage and extensive bone destruction is prevalent 
and finally stage IV which includes osseous ankylosis in 
existing osteoporosis and severe bone destruction. 
  In 1975 Larsen’s grading of radiographic signs included 
six grades that ranged from Grade 0 with “Definitely no 
pathologic findings” to Grade V which denotes “Mutilating 
joint destruction” [16] (Table 4). 
Table  4.  Radiological Grading System for Rheumatoid 
Arthritis 
 
Grade    Radiographic Signs by Larsen 
0  Definitely no pathologic findings  
I  Unspecific pathological findings 
II  Mild, but certain destructive lesions 
III  Moderate destructive lesions 
IV  Severe destructive lesions 
V  Mutilating joint destruction 
 
  More recently Simmen and Huber (1994) differentiated 
three basic types of Rheumatoid Arthritis on a functional 
basis, reliant on a primarily surgical point of view. Type I is 
the Ankylosing subtype, type II is Rheumatoid Arthritis with 
secondary osteoarthritis and finally type III which is 
Rheumatoid Arthritis with disintegration [17]. 
Epidemiology 
  Currently there are almost half a million adults in the 
United Kingdom suffering from rheumatoid arthritis [18]. 
There is age prevalence between the second and fourth 
decades of life, in the adult variant of the disease [1]. 
  Annually approximately 20,000 new cases are diagnosed 
[19]; women are affected three times more commonly than 
men [18]. 
  One in seven patients will give up their employment 
within one year of diagnosis [20], and up to 25 percent of 
working people with rheumatoid arthritis lose their jobs 
within five years; three quarters of these are for reasons 
directly related to their condition [21]. 
  The prevalence of Rheumatoid Arthritis in children is 
difficult to estimate because of differences in nomenclature 
and the heterogeneity of the diseases and the subtypes 
encompassed under this heading [22]. 
Genetic Background and Pathophysiology 
  The most well established genetic link is with HLA-DR4 
[23]. However, this is not consistent across all studied 
cohorts and there are many other newly defined associations, 
including polymorphisms in PTPN22 and PADI4 [24]. 
  IgM or IgG rheumatoid factors are present in more than 
70% of affected patients, rendering them seropositive [25]. 90    The Open Orthopaedics Journal, 2012, Volume 6  Malahias et al. 
  The exact aetiology of Rheumatoid Arthritis remains 
unknown but a model whereby repeated exposure to 
environmental agents is coupled with a genetic predisposition 
to autoimmune responses appears to be reasonable [26]. 
  Of the numerous environmental factors proposed to 
contribute to Rheumatoid Arthritis, tobacco smoking is perhaps 
the best defined. Smoking exposure has a dose response 
relationship with Rheumatoid Arthritis risk [27-29]. 
  Rheumatoid Arthritis usually begins with the proliferation of 
synovial macrophages and fibroblasts after a triggering incident, 
possibly autoimmune or infectious [30]. 
  Matrix Metalloproteinases are produced by the rheumatoid 
synovium; these enzymes break down all components of 
connective tissue. This process is followed by the release of 
cytokines from macrophages; including tumour necrosis factor 
alpha, in addition to numerous Interleukins that degrade bone, 
cartilage, ligament and tendons [26]. Over time, bone erosion 
and irreversible joint damage can occur, leading to permanent 
disability [31]. 
RHEUMATOID ARTHRITIS: CONSERVATIVE AND 
SURGICAL MANAGEMENT 
  The management of Rheumatoid Arthritis is complex; in the 
initial phase of the disease it primarily depends on 
pharmacological management. 
  With disease progression, surgical input to correct deformity 
comes to play an increasingly important role, especially in 
women, who require significantly higher numbers of joint 
replacements than men [32]. The treatment of this condition is 
also intimately coupled with input from both the occupational 
therapists and physiotherapy. 
  The ‘rheumatoid hand’ is one of the earliest presentations of 
Rheumatoid Arthritis, and the progression of its pathology can 
be unpredictable [33]. 
  It is this complexity of the disease and the resulting, 
devastating deformities that demand that such patients are 
management in a coordinated MDT setting [34]. The ultimate 
aim when dealing with Rheumatoid Arthritis is to induce 
complete remission. If remission is unable to be achieved, 
treatment is aimed at controlling disease activity and slowing 
the rate of joint damage [35]. 
Medical 
 Pharmacological treatment of patients with any 
inflammatory arthritis includes primarily the use of non-
steroidal anti-inflammatory medication and cyclo-oxygenase-2 
selective inhibitors. These drugs bring about both anti-
inflammatory, as well as analgesic effects. There is however, no 
scientific proof that they prevent joint damage [36-38]. 
  It is becoming increasingly evident that a ‘critical period’ 
may exist, during which - with aggressive medical intervention - 
the disease process of Rheumatoid Arthritis may be reversed 
[39]. This has resulted in disease modifying antirheumatic drugs 
being used much earlier in the fight against Rheumatoid 
Arthritis, rather than when the pathology has progressed further, 
as previously indicated [39]. 
  Methotrexate treatment for example, has been shown to 
delay the diagnosis of Rheumatoid Arthritis and retarding 
radiographic joint damage [39]. 
  Methotrexate remains the most commonly used, as well as 
most effective monotherapy; it is the recommended standard of 
comparison for new medications [40]. 
  Biologic agents, such as TNF alpha-antagonists, have also 
been added to the resources available against Rheumatoid 
Arthritis. Individuals with no or poor response may be offered 
biologic agents, with a different mechanism of action: Most 
recently Tocilizumab. It is an IL-6 receptor inhibitor, which 
shows swift and significant efficacy in the battle against 
Rheumatoid Arthritis. This has been proven by satisfactory 
remission rates, in addition to a favourable safety profile [40]. 
  It has been shown that patients started on disease modifying 
antirheumatic drug therapy early, exhibit reduced radiographic 
joint damage. They also experience greater preservation of 
function, when compared to patients whose treatment had been 
delayed [39-41]. 
  Hence, current recommendations stipulate that patients who 
are most likely to develop disabling rheumatoid arthritis should 
start disease modifying antirheumatic drugs therapy the earliest 
possible [42]. 
Occupational Therapy 
  The aim of splinting in Rheumatoid Arthritis is to provide 
rest, anatomical and functional support for deformed joints [43, 
45, 50-52]; to decrease inflammation, the subsequent swelling 
and resulting pain [43, 48, 53, 54] during flare ups of the 
condition [44-49, 54-56]. 
  There is however little evidence to validate the effectiveness 
of resting splints. Therapists concur that resting splints have a 
place in the overall management of the Rheumatoid Arthritis 
patient, especially during exacerbations [44]. Resting periods of 
up to three weeks have been proven to be beneficial, longer 
periods on the other hand may result in joint stiffness [48]. 
  Spoorenberg (1994) [57] concluded that resting splints were 
not popular with patients and that only 17% of his study cohort 
wore their splints regularly; mainly due to discomfort, size and 
difficulty with the application. 
  Occupational therapists are therefore encouraged to consider 
their patient’s individual needs, in order to increase compliance 
and to provide the most comfortable and effective aids possible 
[46]. 
Physio Therapy 
 Van  den  Ende  et al., proved that dynamic exercise therapy is 
effective in increasing muscle strength, with out affecting pain 
levels or disease activity [58]. 
  Two more recent studies [59, 60] show that exercise does 
not cause exacerbation of the disease in the short term; long 
term effects, however, are still unknown. 
  Weight reduction for Rheumatoid Arthritis patients, who are 
overweight or obese, limits impact on weight bearing joints and 
improves risk factors for cardiovascular disease. Weight control 
plays an important role in the general disease management [61]. 
Surgery 
  In 2001 Gordon et al., concluded, in a study extending 
over a ten year period, that patients with Rheumatoid   
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Arthritis exhibited a deterioration of radiographs and 
function despite regular Disease Modifying Anti Rheumatoid 
Drug treatment and apparent clinical containment. There was 
a steady requirement for surgical intervention with time [62]. 
  As mentioned previously, more effective and efficient 
medical options are utilised, earlier on in the treatment of the 
affected joint. This results in more restricted pathology and 
slower joint deterioration. Therefore, surgeons have 
observed that the rate of rheumatoid hand surgery has been 
decreasing in the developed world, where costly therapies 
are more readily available [63]. 
  Surgical intervention is typically used when conservative 
therapy is unable to limit the disease evolution towards joint 
instability. Surgical intervention should be considered, 
especially when the instability is associated with 
uncontrollable pain and loss of function [64]. 
  Rheumatoid hand interventions can be categorized into 
prophylactic and therapeutic surgical procedures:  
  Prophylactic procedures include the removal of 
inﬂammatory synovial tissue before synovial hypertrophy 
stretches the ligamentous support around joints, which can 
cause a tendon imbalance, or before synovial tissue invades 
into tendons, causing tendon rupture, or before it destroys 
the articular cartilage [64]. 
  Once the joints are destroyed or the tendons are ruptured, 
surgical options may be considered:  
Wrist 
  Rectifying wrist deformities is often vital to prevent and 
correct hand deformities [65]. Arthrodesis of the wrist offers 
an important possibility in the surgical management of 
rheumatoid disease. In patients with well-preserved 
midcarpal joints, a limited (radiolunate) fusion will preserve 
some wrist motion [66-68]. 
  The Swanson Silastic wrist arthroplasty is an option that 
conserves movement, however careful case selection is vital. 
Arthroplasty is indicated only in patients with long term, 
dormant disease with a very low work demand and 
insufficient bone stock to allow a total wrist arthroplasty 
with a metal on plastic design [69-74]. 
Extensor Tendons 
  Tenosynovitis of the extensors is a relatively early finding in 
rheumatoid disease. Mechanical abrasion by dorsal wrist 
osteophytes may cause rupture of theses structures. Ischemia 
from pannus or direct invasion may also result in erosion of 
extensor tendons [75]. Dorsal tenosynovectomy is 
recommended for tenosynovitis that has resisted six months of 
medical management [76-78]. 
Flexor Tendons 
  ‘Mannerfelt lesion’ is responsible for flexor pollicis longus 
rupture. This is the most common flexor tendon rupture in the 
rheumatoid hand and results from tendon erosion by direct 
friction against the scaphoid bone [79]. 
  Flexor digitorum profundus and superficialis ruptures are 
usually due to direct synovial infiltration of the tendons [80] and 
attrition ruptures are unusual [81]. Flexor Digitorum Profundus 
tenosynovitis usually manifests as carpal tunnel syndrome or 
trigger digits. In such cases the carpal tunnel may be 
decompressed. For trigger fingers, the A 1 pulley should not be 
released, as it may be the only remaining supporting structure 
for the metacarpo-phalangeal joint. If synovectomy is not 
sufficient, then excising a slip of the Flexor Digitorum 
Superficialis could solve the restriction, by thinning the tendon. 
MP Joints 
  Early disease of the MP joints can be addressed by 
synovectomy, which alleviates pain [82]. 
  With extensive metacarpo phalangeal joint pathology, 
replacement arthroplasty may be indicated. Silicone arthroplasty 
of these joints is commonly performed, unlike with the wrist 
and in the thumb CMC joint where silicone arthroplasty has 
fallen out of favor [83-85]. 
  Recurrent ulnar drift (31%), implant fracture (26%) and 
silicone synovitis represent possible complications of silicone 
joint replacements [86-90]. 
Finger Joints 
  Early synovectomy, to avoid the progressive synovitis that 
ultimately displaces and infiltrates the extensor mechanism is 
indicated. It is the preferred treatment, to conserve as much joint 
function as possible [91, 92]. 
  Frozen PIP joints only respond to fusion or arthroplasty 
[93]. 
Thumb 
  Metacarpophalangeal joint synovectomy is indicated early 
on and may be combined with extensor mechanism 
modification such as Extensor Pollicis Longus rerouting or 
Extensor Pollicis Brevis advancement [94]. 
  The recommended surgical treatment for mild to moderate 
swan-neck deformities is implant hemiarthroplasty. When there 
is advanced deformity, resection arthroplasty, combined with 
volar tenodesis of the joint may be performed. An alternative 
option to this is joint fusion, with release of the fascia of the first 
dorsal interosseous muscle [95]. 
  Arthrodesis is recommended for moderate deformities, 
when the metacarpophalangeal joint is totally destroyed but the 
remainder of the thumb ray is only minimally involved. If 
destructive changes are evident at either the carpometacarpal or 
interphalangeal levels, metacarpophalangeal arthroplasty is 
preferred. 
Allotransplant: The Future? 
 Iglesias  et al. recently propose to perform an allotransplant 
of the osteomyotendinous structures in patients with 
Rheumatoid Arthritis, by comparing them to trauma patients, 
that receive allotransplants coupled with immunosuppressant 
medication, to ensure the graft’s survival [96]. 
  The basis for their hypothesis is that between 1998 and 
2009, 42 hand and three arm allotransplants in 33 patients 
have been performed worldwide; after a follow-up from 17 
to 120 months, 25 of these transplants are still viable [97]. 
  Iglesias also drew on the similarity between the 
medication used by both the trauma patients on 
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  Both groups of patients are often treated with non-
steroidal drugs, corticosteroids, Methotrexate, Azathioprine, 
and monoclonal antibodies [98-101]. 
  They set out to prove the feasibility of their hypothesis 
by operating on ten cadavers; the average operative time was 
approximately 20 hours. 
  Their approach specified the preservation of the 
recipient’s skin ﬂap and sensory nerves, to render the graft, 
psychologically more acceptable and functionally superior, 
for the patient [96]. 
DISCUSSION 
  A recent study, by Amy K Alderman, found that 70% of 
rheumatologists consider hand surgeons deficient in 
understanding the medical options available for Rheumatoid 
Arthritis, while 73.6% of surgeons believe rheumatologists 
have insufficient knowledge of the surgical options for the 
rheumatoid hand [102]. 
  Mc Ewen and Chung KC had already confirmed with 
their preceding studies, that surgical outcomes research is 
limited for physicians managing RA hand deformities 
[103,104]. 
  It is has therefore been proven, that both rheumatologists 
and hand surgeons have minimal interdisciplinary training, 
restricted interdisciplinary communication regarding clinical 
management and disagree significantly on the timing and 
indications for hand surgery [102]. 
  Clinical pathways, with a multidisciplinary approach in 
mind, that include hand surgeons, rheumatologists and 
occupational therapists, are useful clinics that are more 
convenient for patients and more successful in targeted 
disease management [102,103]. 
CONCLUSION 
  The diagnosis and management of Rheumatoid Arthritis 
is a fast evolving field and it is important to keep up to date 
with the latest information. 
  One important step is to prevent a disarticulated 
approach, when managing a patient. Early involvement of all 
specialists and a coordinated treatment plan in an MDT 
setting is vital to successfully deal with the signs and 
symptoms of a Rheumatoid Arthritis patient. 
  As mentioned above, the current recommendations are 
that patients should start disease modifying antirheumatic 
treatment at the earliest possible opportunity to delay the 
degeneration of joint integrity. 
  The decision for surgical intervention must be based on 
its overall ability to address the patient’s primary wishes and 
needs. Although there have been tremendous advances in the 
surgical armamentarium, the role of specific procedures has 
many areas of uncertainty and controversy. 
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